In August 2019, Elanco Animal Health Incorporated (NYSE: ELAN) entered into an agreement with Bayer AG (ETR: BAYN) to acquire its animal health business in a transaction valued at US$7.6 billion. The transaction is expected to close in mid-2020, subject to regulatory approvals and other customary closing conditions.
Duff & Phelps served as financial advisor to the board of directors of Elanco and provided a fairness opinion in connection with the transaction.
Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 65-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life — all to advance the health of animals, people and the planet. Paul, Weiss, Rifkind, Wharton & Garrison LLP and Hengeler Mueller acted as legal counsel to Elanco.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros.
Comprehensive support throughout mergers and acquisitions and other corporate transactions.
Middle-market M&A advisory differentiated by industry expertise and superior deal execution.
Transaction Advisory Services
Seamless analytical advisory through the deal continuum, from transaction origination to closing.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Private Capital Markets
Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.
Fairness and Solvency Opinions
Independent opinions for boards of directors and special committees.
Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.
Property tax, site selection, transfer pricing, sales and use tax and unclaimed property advisory.
has completed a debt for equity exchange as part of a restructuring transaction
has completed a recapitalization and financial restructuring transaction
has been acquired by
a portfolio company of
has signed a binding offer to acquire five data centers from
Macy’s, Inc. (NYSE:M), has completed a refinancing transaction, raising approximately $4.5 billion of new financing, including an asset-based credit line and the issuance of senior secured notes
has sold its passive infrastructure to
Gregory Burkart Talks Manufacturing Reshoring on Site Selection Matters Podcast
Simon Webber, Judd Schneider and David Ptashne in Tax Notes: Intangible Asset Valuation Considerations
Duff & Phelps Partners with NYU Stern School of Business